fulvestrant has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, R; Crawford, AC; Riggins, RB; Shajahan, AN; Zwart, A | 1 |
| Gyun Jung, C; Hayashi, Y; Hida, H; Kodama, Y; Kohri, K; Mogami, M; Nishino, H | 1 |
2 other study(ies) available for fulvestrant and Necrosis
| Article | Year |
|---|---|
Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cell Line, Tumor; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Humans; Necrosis; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering | 2010 |
Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Bradykinin; Brain; Calcium; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Immunohistochemistry; In Situ Nick-End Labeling; Necrosis; Nitro Compounds; Propionates; Rats; Rats, Wistar; Tamoxifen; von Willebrand Factor | 2002 |